Our management board and team

Dr. Torsten Woehr

• Chief Executive Officer of Rentschler Biopharma since August 2026
• Brings more than 25 years of experience in the biopharmaceutical industry, including the last 20 years in the CDMO sector across both publicly listed and private equity-backed companies
• Prior to joining Rentschler Biopharma, spent nine years at Bachem AG, where he held leadership positions of increasing responsibility, culminating in his appointment as Chief Commercial Officer and member of the Corporate Executive Committee
• Led Bachem’s global commercial organization, helped shape the company’s growth strategy, supported major investments to expand peptide manufacturing capacities. Also led the successful initiative to extend the technology platform to include the manufacturing of oligonucleotide-based active pharmaceutical ingredients
• Began his career working in Regulatory Affairs at Johnson & Johnson in Zurich
• Spent more than a decade in the Boston biotech hub, including leadership roles at CDMOs Corden Pharma and Genzyme Pharmaceuticals
• Holds an MSc in Biochemistry and Molecular Biology from the ETH in Zürich, PhD in Bio-organic Chemistry from the University of Lausanne / EPFL, Switzerland
• He eventually returned to the ETH in Zürich for an MBA in Industrial Engineering and General Management

See Full CV

Dr. Veit Bergendahl

• Holds a degree in biochemistry and a doctorate in biology from Philipps University, Marburg     
• Professional activity in the USA: Conducted research at the University of Wisconsin-Madison and held leadership positions at Cellular Dynamics International Inc
• Senior position in Germany at Roche and Miltenyi Biotec  
• Various positions at Boehringer Ingelheim: Associate Director CMC PM Biopharmaceuticals, and scientific expert for Boehringer Ingelheim's bioassay strategy 
• Executive Director Upstream Manufacturing, overseeing a large-scale production facility of Boehringer Ingelheim  
• Head of Clinical Supply Biologicals, responsible for the commissioning and go-live of the Boehringer Ingelheim Biologicals Development Center at the company’s R&D site in Biberach, Germany 

See full CV

Gunnar Voss van Dahlen

• Over 17 years of experience as a CFO in internationally active, mid-sized private and public companies
• Expertise in finance, controlling, law, IT, and human resource management
• International management positions in the US, UK, Singapore, and Switzerland
• Since December 2023, Financial Officer at Rentschler Biopharma SE 

See full CV

Tobias Glueck

• Vice President Human Resources at Cameron
• Managing Director People & Organization at Novartis Germany GmbH
• Since October 2022, Global Head of Human Relations at Rentschler Biopharma and since February 2023, member of the Extended Executive Team

See full CV

Dr. Patrick Meyer

• PhD degree in molecular medicine and cellular biology
• Global Head BD Sales and Alliance Management at Rentschler Biopharma SE
• Since February 2025, Member of Executive Committee at Rentschler Biopharma SE
• Since February 2025, Global Head of Business Development at Rentschler Biopharma SE

See full CV

Tom Roberts

• Leadership positions at Invictus Medical, 3M – KCI (formerly Acelity) and Roche Diagnostics
• Executive leadership, facilitated funding, and oversaw business and product development, regulatory compliance, manufacturing, and technology acquisition of a groundbreaking nanoparticle-based combination cancer therapeutic at Vitanova Biomedical
• Since September 2023, President Rentschler Biopharma Inc. and General Manager U.S., and member of the company’s Extended Executive Team

See full CV

Andreas Loewe

• Biological technical assistant in cGMP production at Fresenius
• Vice President Controlling and Member Management Executive Committee at Fresenius SE
• Vice President Controlling, Procurement and Projects at Neovii Biotech
• Since 2020 Vice President Finance at Rentschler Biopharma
• Since June 2023 part of the Extended Management Team

See full CV